Desq Long
Sign in

Company

CRISPR Therapeutics AG

CRSP · CIK 0001674416

SEC FORM 4
$141,648.00

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 10,400 shares at $13.62 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code M

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401237 · filed 2026-09-24 · View filing →

SEC FORM 4
$626,459.60

CRISPR Therapeutics AG (CRSP)

Sale of 10,400 shares at $60.2365 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401237 · filed 2026-09-24 · View filing →

SEC FORM 4
$420,000.00

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 30,000 shares at $14 per share.

Reporting Person Behbahani Ali · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396944 · filed 2026-09-21 · View filing →

SEC FORM 4
$780,935.48

CRISPR Therapeutics AG (CRSP)

Sale of 13,679 shares at $57.0901 per share.

Reporting Person Behbahani Ali · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396944 · filed 2026-09-21 · View filing →